Explore

Rapid Read Rapid Read
Scientists Develop Computer Model to Simulate Alzheimer's Disease Spread in Brain

Scientists Develop Computer Model to Simulate Alzheimer's Disease Spread in Brain

Researchers have created a new computer model that simulates the spread of Alzheimer's disease through the brain, highlighting the impact of the brain's physical structure on disease progression. The study, published in the journal Computer Methods in Applied Mechanics and Engineering, combines the movement of toxic proteins, such as amyloid-beta and tau, with the brain's structural changes as the disease advances. This model aims to provide a deeper understanding of how microscopic changes lead to large-scale brain damage. The model incorporates the brain's white matter fiber tracts, which serve as routes for disease spread, and accounts for the brain's physical deformation due to tissue atrophy. The simulations have shown good agreement with real-world disease progression, suggesting the framework captures important features of Alzheimer's.
Rapid Read Rapid Read
Study Suggests Most Neurons Are Generalists, Not Specialists

Study Suggests Most Neurons Are Generalists, Not Specialists

A study conducted by researchers at Columbia University challenges the long-held belief that neurons are highly specialized. The research, involving mice, indicates that most neurons are generalists, capable of responding to multiple task-related inputs simultaneously. This finding suggests that the brain's functionality is more flexible and adaptable than previously thought, with neurons playing diverse roles in processing information.
Rapid Read Rapid Read
Bioengineering Advances: Hybrid Living Models Enhance Vascular Disease Research

Bioengineering Advances: Hybrid Living Models Enhance Vascular Disease Research

Recent developments in bioengineering have introduced hybrid living models that integrate both the bath and bioink as active components. These models are particularly promising for creating perfusable tubes with stiffness gradients and spatial heterogeneity of cell types, which are crucial for reconstructing vascularized tissue microenvironments. This approach allows for the exploration of interactions between arteries and their surrounding tissue environment, providing insights into various vascular diseases. The models are designed to mimic the structural and functional aspects of human vessels, enabling researchers to study the etiology of vascular diseases more effectively. The focus is on developing disease-aligned toolchains, including standardized bioinks and validated perfusion protocols, to deliver actionable physiological insights.
Rapid Read Rapid Read
Enveda's ENV-294 Shows Promising Results in Atopic Dermatitis Trial

Enveda's ENV-294 Shows Promising Results in Atopic Dermatitis Trial

Enveda Biosciences has announced positive results from its Phase 1b trial of ENV-294, a potential first-in-class oral therapy for moderate-to-severe atopic dermatitis. The trial, presented at the American Academy of Dermatology Innovation Academy, showed that patients experienced significant improvements in their Eczema Area and Severity Index (EASI) scores, with a mean reduction of 68% by Day 28 and 85% by Day 42. The study involved nine patients, all of whom achieved EASI-50 by Day 42, with 78% reaching EASI-75 and 56% achieving EASI-90. The drug was generally well-tolerated, with only one reported headache as an adverse event.
Rapid Read Rapid Read
Xenotransplantation Advances with New Clinical Trials

Xenotransplantation Advances with New Clinical Trials

Xenotransplantation, the transplantation of animal organs into humans, is entering a new era with significant advancements in clinical trials. Researchers at Massachusetts General Hospital, led by Tatsuo Kawai and Leonardo Riella, are using CRISPR gene-editing technology to enhance the compatibility of pig organs with human hosts. Recent trials have shown promising results, with pig kidneys successfully functioning in monkeys for extended periods. In 2024, a genetically edited pig kidney was transplanted into a human patient, marking a milestone in the field. Although the patient later died from unrelated causes, the trial provided valuable data that has paved the way for larger clinical trials. These trials aim to test the safety and efficacy of pig kidneys in human patients, potentially addressing the critical shortage of human donor organs.
Rapid Read Rapid Read
Study Finds Temporary Reversal of Autism-Like Brain Changes in Mice

Study Finds Temporary Reversal of Autism-Like Brain Changes in Mice

A study conducted by UCLA Health has found that short-term immunosuppressive therapy using the drug rapamycin can temporarily reverse autism-like brain changes in adult mice. The research indicates that inflammation during pregnancy can lead to autism-like symptoms in offspring, but these effects may be rapidly reversible in adulthood. The study highlights the potential for new therapeutic targets, focusing on brain functional circuitry rather than structural changes, to address autism-associated symptoms.
Rapid Read Rapid Read
New Computational Model Suggests Brain Structure Influences Alzheimer's Progression

New Computational Model Suggests Brain Structure Influences Alzheimer's Progression

Researchers from the University of Oviedo and the University of Oxford have developed a new computational model that simulates the spread of Alzheimer's disease in the brain. This model incorporates the movement of toxic proteins, such as amyloid-beta and tau, alongside the progressive shrinking and deformation of brain tissue. The study, published in the journal Computer Methods in Applied Mechanics and Engineering, highlights how the brain's physical structure can significantly alter the progression of Alzheimer's. The model uses reaction-diffusion equations to mimic the prion-like behavior of these proteins and includes the brain's white matter fiber tracts, which serve as pathways for disease spread. The research suggests that the physical state of the brain is not merely a consequence of Alzheimer's but may also affect how the disease unfolds.
Rapid Read Rapid Read
Discovery of Brain Lymphatic Network Offers New Pathways for Treating Neurodegenerative Diseases

Discovery of Brain Lymphatic Network Offers New Pathways for Treating Neurodegenerative Diseases

Scientists have discovered a hidden lymphatic network in the brain, solving a long-standing mystery in brain anatomy. This network, identified as 'arachnoid fenestrations,' allows cerebrospinal fluid to drain from the brain into the lymphatic system. The study, led by researchers at the Institute for Basic Science in South Korea, highlights the role of these structures in clearing metabolic waste from the brain, which is crucial for preventing the accumulation of toxic proteins associated with Alzheimer's and Parkinson's diseases. The research shows that these structures deteriorate with age, potentially contributing to the onset of neurodegenerative diseases.
USA Today USA Today
USA250: 10 greatest college athletes from Michigan

USA250: 10 greatest college athletes from Michigan

As part of USA TODAY Sports' USA 250 initiative, here's a look at the top 10 greatest college athletes to ever play in the state of Michigan:
Trendline Trendline
University of Michigan Faces Systemic Issues Amidst Athletic Department Scandal

University of Michigan Faces Systemic Issues Amidst Athletic Department Scandal

University of Michigan Faces Systemic Issues Amidst Athletic Department Scandal
Rapid Read Rapid Read
Cold Spring Harbor Laboratory Scientists Revive Vancomycin to Combat Superbugs

Cold Spring Harbor Laboratory Scientists Revive Vancomycin to Combat Superbugs

Researchers at Cold Spring Harbor Laboratory (CSHL), led by Professor John Moses, have developed a method to restore the effectiveness of vancomycin, a powerful antibiotic that had become less effective against certain drug-resistant bacteria. The team utilized a technique called diversity oriented clicking (DOC) to create a library of over 150 compounds. In collaboration with Scripps Research, they identified a small molecule, pghi-4, which inhibits a bacterial enzyme called secreted antigen A (SagA). This inhibition allows vancomycin to regain its ability to kill drug-resistant strains of E. faecium, a pathogen known for causing severe infections. The research highlights the potential of using existing drugs in combination with new molecules to combat antibiotic resistance.
Trendline Trendline
Golden State Warriors Win NBA Summer League Title Led by Yaxel Lendeborg

Golden State Warriors Win NBA Summer League Title Led by Yaxel Lendeborg

Golden State Warriors Win NBA Summer League Title Led by Yaxel Lendeborg